Kiniksa Pharmaceuticals, Ltd. (KNSA) Financials

KNSA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 825.3 million 219.6 million
Dec. 31, 2025 763.6 million 196.0 million
Sept. 30, 2025 712.3 million 177.0 million
June 30, 2025 661.2 million 166.1 million

KNSA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 50.0 million 10.1 million
Dec. 31, 2025 53.3 million 3.9 million
Sept. 30, 2025 33.0 million 10.1 million
June 30, 2025 27.9 million 8.9 million

KNSA Net Income

No data available :(

KNSA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 468.1 million - 9.0 million
Dec. 31, 2025 414.1 million 6.5 million 9.5 million
Sept. 30, 2025 352.1 million - 9.7 million
June 30, 2025 307.8 million - 9.8 million

KNSA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 82.4 million
Dec. 31, 2025 79.0 million
Sept. 30, 2025 78.0 million
June 30, 2025 77.9 million

KNSA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 161000 27.5 million 61.2 million -
Dec. 31, 2025 633000 34.6 million 56.8 million -
Sept. 30, 2025 671000 24.1 million 49.1 million -
June 30, 2025 165000 18.8 million 46.9 million -

KNSA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 214.3 million 96.4 million
Dec. 31, 2025 202.1 million 91.1 million
Sept. 30, 2025 180.9 million 83.6 million
June 30, 2025 156.8 million 71.0 million

KNSA Revenue by Segment
Graph available only for paid members. Upgrade to see it.

KNSA

Price: $48.42

52 week price:
24.85
59.48

Earnings Per Share: 0.95 USD

P/E Ratio: 60.65

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Bermuda

Volume: 221500

Market Capitalization: 4.3 billion

Links: